249 related articles for article (PubMed ID: 10325788)
21. Screening for cystic fibrosis in newborn infants: results of a pilot programme based on a two tier protocol (IRT/DNA/IRT) in the Italian population.
Corbetta C; Seia M; Bassotti A; Ambrosioni A; Giunta A; Padoan R
J Med Screen; 2002; 9(2):60-3. PubMed ID: 12133923
[TBL] [Abstract][Full Text] [Related]
22. Two-tiered immunoreactive trypsinogen-based newborn screening for cystic fibrosis in Colorado: screening efficacy and diagnostic outcomes.
Sontag MK; Hammond KB; Zielenski J; Wagener JS; Accurso FJ
J Pediatr; 2005 Sep; 147(3 Suppl):S83-8. PubMed ID: 16202790
[TBL] [Abstract][Full Text] [Related]
23. Cystic fibrosis newborn screening in Denmark: Experience from the first 2 years.
Skov M; Baekvad-Hansen M; Hougaard DM; Skogstrand K; Lund AM; Pressler T; Olesen HV; Duno M
Pediatr Pulmonol; 2020 Feb; 55(2):549-555. PubMed ID: 31682332
[TBL] [Abstract][Full Text] [Related]
24. Cost-effectiveness of newborn screening for cystic fibrosis determined with real-life data.
van der Ploeg CP; van den Akker-van Marle ME; Vernooij-van Langen AM; Elvers LH; Gille JJ; Verkerk PH; Dankert-Roelse JE;
J Cyst Fibros; 2015 Mar; 14(2):194-202. PubMed ID: 25213034
[TBL] [Abstract][Full Text] [Related]
25. Neonatal screening strategy for cystic fibrosis using immunoreactive trypsinogen and direct gene analysis.
Ranieri E; Ryall RG; Morris CP; Nelson PV; Carey WF; Pollard AC; Robertson EF
BMJ; 1991 May; 302(6787):1237-40. PubMed ID: 2043846
[TBL] [Abstract][Full Text] [Related]
26. A product of immunoreactive trypsinogen and pancreatitis-associated protein as second-tier strategy in cystic fibrosis newborn screening.
Weidler S; Stopsack KH; Hammermann J; Sommerburg O; Mall MA; Hoffmann GF; Kohlmüller D; Okun JG; Macek M; Votava F; Krulišová V; Balaščaková M; Skalická V; Lee-Kirsch MA; Stopsack M
J Cyst Fibros; 2016 Nov; 15(6):752-758. PubMed ID: 27461140
[TBL] [Abstract][Full Text] [Related]
27. Lessons learned from 20 years of newborn screening for cystic fibrosis.
Massie RJ; Curnow L; Glazner J; Armstrong DS; Francis I
Med J Aust; 2012 Jan; 196(1):67-70. PubMed ID: 22256939
[TBL] [Abstract][Full Text] [Related]
28. Risk calculations for cystic fibrosis in neonatal screening by immunoreactive trypsinogen and CFTR mutation tests.
Ogino S; Flodman P; Wilson RB; Gold B; Grody WW
Genet Med; 2005; 7(5):317-27. PubMed ID: 15915083
[TBL] [Abstract][Full Text] [Related]
29. Markedly elevated neonatal immunoreactive trypsinogen levels in the absence of cystic fibrosis gene mutations is not an indication for further testing.
Massie J; Curnow L; Tzanakos N; Francis I; Robertson CF
Arch Dis Child; 2006 Mar; 91(3):222-5. PubMed ID: 16243854
[TBL] [Abstract][Full Text] [Related]
30. Secondhand Smoke Exposure and Serum Trypsinogen in Cystic Fibrosis Carriers.
Ellery KM; Kopp B; Conwell DL; Gariepy C
Pancreas; 2019 Oct; 48(9):1155-1159. PubMed ID: 31593019
[TBL] [Abstract][Full Text] [Related]
31. Cystic fibrosis carriers have higher neonatal immunoreactive trypsinogen values than non-carriers.
Castellani C; Picci L; Scarpa M; Dechecchi MC; Zanolla L; Assael BM; Zacchello F
Am J Med Genet A; 2005 Jun; 135(2):142-4. PubMed ID: 15832355
[TBL] [Abstract][Full Text] [Related]
32. Thirty-years of screening for cystic fibrosis in East Anglia.
Calvin J; Hogg SL; McShane D; McAuley SA; Iles R; Ross-Russell R; MacLean FM; Heeley ME; Heeley AF;
Arch Dis Child; 2012 Dec; 97(12):1043-7. PubMed ID: 23076339
[TBL] [Abstract][Full Text] [Related]
33. A survey of newborn screening for cystic fibrosis in Europe.
Southern KW; Munck A; Pollitt R; Travert G; Zanolla L; Dankert-Roelse J; Castellani C;
J Cyst Fibros; 2007 Jan; 6(1):57-65. PubMed ID: 16870510
[TBL] [Abstract][Full Text] [Related]
34. Utility of a very high IRT/No mutation referral category in cystic fibrosis newborn screening.
Kay DM; Langfelder-Schwind E; DeCelie-Germana J; Sharp JK; Maloney B; Tavakoli NP; Saavedra-Matiz CA; Krein LM; Caggana M; Kier C;
Pediatr Pulmonol; 2015 Aug; 50(8):771-80. PubMed ID: 26098992
[TBL] [Abstract][Full Text] [Related]
35. Screening for cystic fibrosis in New York State: considerations for algorithm improvements.
Kay DM; Maloney B; Hamel R; Pearce M; DeMartino L; McMahon R; McGrath E; Krein L; Vogel B; Saavedra-Matiz CA; Caggana M; Tavakoli NP
Eur J Pediatr; 2016 Feb; 175(2):181-93. PubMed ID: 26293390
[TBL] [Abstract][Full Text] [Related]
36. Optimization of performance of Dutch newborn screening for cystic fibrosis.
Bouva MJ; Dankert-Roelse JE; van der Ploeg C; Verschoof-Puite RK; Zomer-van Ommen DD; Gille J; Jakobs BS; Heijnen M; de Winter-de Groot KM
J Cyst Fibros; 2024 Jan; 23(1):120-125. PubMed ID: 37716879
[TBL] [Abstract][Full Text] [Related]
37. Immunoreactive trypsinogen levels in newborn screened infants with an inconclusive diagnosis of cystic fibrosis.
Ooi CY; Sutherland R; Castellani C; Keenan K; Boland M; Reisman J; Bjornson C; Chilvers MA; van Wylick R; Kent S; Price A; Mateos-Corral D; Hughes D; Solomon M; Zuberbuhler P; Brusky J; Durie PR; Ratjen F; Gonska T
BMC Pediatr; 2019 Oct; 19(1):369. PubMed ID: 31640630
[TBL] [Abstract][Full Text] [Related]
38. Newborn screening for cystic fibrosis in Wisconsin: comparison of biochemical and molecular methods.
Gregg RG; Simantel A; Farrell PM; Koscik R; Kosorok MR; Laxova A; Laessig R; Hoffman G; Hassemer D; Mischler EH; Splaingard M
Pediatrics; 1997 Jun; 99(6):819-24. PubMed ID: 9164776
[TBL] [Abstract][Full Text] [Related]
39. Newborn cystic fibrosis screening in southeastern Mexico: Birth prevalence and novel CFTR gene variants.
Ibarra-González I; Campos-Garcia FJ; Herrera-Pérez LDA; Martínez-Cruz P; Moreno-Graciano CM; Contreras-Capetillo SN; León-Burgos V; Maldonado-Solis FA; Alcántara-Ortigoza MA; González Del Angel A; Vela-Amieva M
J Med Screen; 2018 Sep; 25(3):119-125. PubMed ID: 28992757
[TBL] [Abstract][Full Text] [Related]
40. Negative sweat test in hypertrypsinaemic infants with cystic fibrosis carrying rare CFTR mutations.
Padoan R; Bassotti A; Seia M; Corbetta C
Eur J Pediatr; 2002 Apr; 161(4):212-5. PubMed ID: 12014388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
